Informação sobre produto
- (6R)-2-Methyl-6-[(1R,3aS,4E,7aR)-octahydro-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]-7a-methyl-1H-inden-1-yl]-1,2-heptanediol
- 1,2-Heptanediol, 2-methyl-6-[(1R,3aS,4E,7aR)-octahydro-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]-7a-methyl-1H-inden-1-yl]-, (6R)-
- 25,26-Dihydroxycholecalciferol
- 25,26-Dihydroxyvitamin D
- 25,26-Dihydroxyvitamin D<sub>3</sub>
- 29261-12-9
- 9,10-Secocholesta-5,7,10(19)-triene-3,25,26-triol, (3β,5Z,7E)-
- 9,10-Secocholesta-5,7,10(19)-triene-3β,25,26-triol
25,26-Dihydroxyvitamin D3 is a synthetic product that inhibits the growth of breast cancer cells. This compound is structurally similar to vitamin D3 and has been shown to inhibit the growth of animals with colon cancer. It has also been used in humans to inhibit the growth of breast cancer cells. 25,26-Dihydroxyvitamin D3 inhibits cell proliferation by decreasing the levels of plasma concentrations of hydroxy group and human serum albumin as well as inhibiting protein synthesis in intestinal cells and tubule cells. The effects on these different types of cells may be due to its ability to form isomers with vitamin D3.
Propriedades químicas
Consulta técnica sobre: 3D-EBA26112 25,26-Dihydroxyvitamin D3
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
